A DEXA Clinical Study to Evaluate the Osteointegrative Potential of Trabecular Titanium™
- Conditions
- Primary Total Hip Replacement
- Interventions
- Device: Delta TT acetabular cup
- Registration Number
- NCT02635581
- Lead Sponsor
- Limacorporate S.p.a
- Brief Summary
The purpose of this clinical trial is to evaluate the osteointegrative potential of the Trabecular TitaniumTM and to measure the pattern of changing in bone mineral density (BMD) around an uncemented acetabular cup, manufactured in Trabecular Titanium™ , during 60 months after surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 84
- BMI< 40 kg/m2
- Indication suitable to the implantation of Delta TT acetabular cup (First implant)
- Idiopathic osteoarthritis
- Avascular necrosis
- Post-traumatic arthritis
- Presence of sufficient periacetabular bone stock
- Ability to understand the investigation, cooperate with the investigational procedure and willing to return to the hospital for the required post-operative follow-ups
- Written informed consent
- Patients found unsuitable for an implantation of Delta TT acetabular cup (Revision)
- Patients aged 76 or older
- Haemophilic disease
- Femur neck fracture
- Insulin Dependent Diabetes Mellitus (IDDM)
- Severe kidney failure (grade 4)
- Not responder Hypo- or Hyperthyroidism
- Paget's disease
- Tumours
- Active or suspicious infections
- Neurosensory deficits or neuromuscular diseases
- Severe and impairing vascular diseases
- Known incompatibility or allergy to products materials
- Woman with pregnancy or childbearing capacity or breast-feeding
- Subjects already enrolled in other clinical trials
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description DELTA TT Delta TT acetabular cup -
- Primary Outcome Measures
Name Time Method The percentage change of the bone mineral density (BMD) around the acetabular cups with DEXA scan From baseline to 5 year Follow-up
- Secondary Outcome Measures
Name Time Method Harris Hip Score (HHS) From baseline to 5 year Follow-up SF-36 score From baseline to 5 year Follow-up
Trial Locations
- Locations (4)
Azienda Ospedaliero-Universitaria di Ferrara, Arcispedale S. Anna
🇮🇹Cona, Ferrara, Italy
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Dipartimento di Ortopedia, Traumatologia e Riabilitazione, Ospedale CTO, Clinica II
🇮🇹Torino, Italy
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Dipartimento di Ortopedia, Traumatologia e Riabilitazione, Ospedale CTO, Clinica I
🇮🇹Torino, Italy
Azienda Ospedaliero-Universitaria di Udine, Santa Maria della Misericordia
🇮🇹Udine, Italy